KL2-Mentored Clinical and Translational Research Scholars Program


KL2 Application Workshops

A free two-session KL2 application workshop for KL2 applicants will be held on December 3 AND December 10, 2020, from 9:00 until 11:00 a.m. via Zoom to provide a detailed review of the application process and tips on how to put together a competitive application. To register for this free workshop, e-mail Dr. Janet Gross (jsgros2@emory.edu) and Cheryl Sroka (csroka@emory.edu). Include your name, position, department, school, title of research study, mentor’s name and department, and NIH biosketch. Those who attend BOTH workshops will be eligible for up to 5 hours of individual grant writing consultation. Applicants to the KL2 program are STRONGLY recommended but not required to attend the workshop. View prior KL2 application workshop session 1 and session 2.

Purpose

The goal of the Georgia CTSA KL2-Mentored Clinical and Translational Research Scholars program is to support and enhance career development for junior faculty (MD, PhD, MD/PhD, or PharmD) from a wide variety of disciplines at Emory University, Morehouse School of Medicine (MSM), Georgia Institute of Technology (Georgia Tech), and University of Georgia (UGA). The Georgia CTSA KL2 Core is committed to assisting junior faculty at partner institutions to become independent, established, and ethical clinical and/or translational research investigators. Trainees accepted into the KL2 Scholars program will receive salary support to enable them to spend at least 75% of their professional time (50% is allowed for trainees from surgery or surgical subspecialties) on clinical and/or translational research and research training and a technical budget $25,000 per year for research-related expenses and tuition for the Master of Science in Clinical Research (MSCR) degree or Certificate Program in Translational Research (CPTR) curriculum. Second year of funding is contingent upon adequate progress of year 1. Didactic research training is provided through the required MSCR or CPTR programs and mentored research training under the direction of an established, federally-funded clinical investigator at one of the collaborating institutions. Support in the program will be provided for up to two years and is based on performance in the program.

The KL2 program provides the opportunity to build upon the resources of the Georgia CTSA and other established programs in supporting junior faculty members who want to establish a successful clinical and/or translational research career. The KL2 program provides the opportunity for didactic training (in large part through the MSCR or CPTR programs) and also requires that the trainee have an established and successful lead mentor (as well as an Advisory Committee) who could provide further guidance and training for those pursuing careers in clinical and/or translational investigation.

Acknowledgments

All publications derived from work supported by the KL2 award must acknowledge the Georgia CTSA KL2-Mentored Clinical and Translational Research Program and NIH KL2 support under Award Number UL1TR002378 and KL2TR002381.

More Information

KL2 Application Deadline: March 1, 2021 5:00 PM (EST)

The KL2 program responds to national efforts to support the training and development of junior faculty members who will become well trained, successful, and independent clinical and/or translational investigators. The KL2 program builds on the considerable strengths and outstanding resources in Atlanta and at Emory, MSM, Georgia Tech, and UGA.

The Georgia CTSA KL2 addresses the recommendations of the National Academy of Medicine and others about the need to intensify efforts to train and retain clinical and translational researchers in order to reverse the dramatic decline of clinical and/or translational investigators entering the research workforce. The rationale for the education and training program includes the expanding need for high-quality clinical and translational research; the necessity for integration of the analytic sciences and clinical and translational research; the need to translate research findings from the bench to the bedside and from the bedside to the community; the importance of interdisciplinary education and training in clinical and translational research; and the extensive expertise in and record of clinical investigation represented by the faculty at the collaborating institutions (i.e., Emory, MSM, Georgia Tech, and UGA).

The MSCR or CPTR programs at either Emory or MSM provide didactic training for those applicants from the respective institutions accepted into the KL2 program. All applicants accepted into the Georgia CTSA KL2 program will be required to enroll in the MSCR program (either at Emory or MSM) or CPTR, although students can take courses in either program and there are some joint courses. The Emory MSCR program is offered by the James T. Laney School of Graduate Studies.

The Emory MSCR program requires a minimum of 30 hours of academic credit that include in-class didactic coursework and a written research thesis. Generally, three semesters of didactic study (10-12 months minimum for full-time students) are required and an optimal time of 18-24 months to complete the program (including the mentored thesis). For most investigators, the period of two years is appropriate to accomplish both the didactic work (one year) and completion of an appropriate investigative research thesis.

The MSM MSCR program is a broad-based multidisciplinary graduate level program in clinical and translational research designed to address the problem of health disparities and the shortage of clinical and translational researchers through a concerted effort to recruit and train doctoral prepared minority candidates for successful careers in clinical and translational research.  The program provides training in the principles and methods of biostatistics, epidemiology, including genetics and clinical trials, big data and informatics, and outcomes research, including health services research, patient centered outcomes research methods and community engagement.

An investigator initiated, hypothesis driven proposal with specific aims will be developed by each trainee. The research proposal must have a “human component,” i.e. interaction with human subjects or specimens obtained from identifiable humans. This will be initially outlined in the application submitted by candidates for the program and will be further refined after enrollment in the KL2 program. If the KL2 scholar’s research project involves a clinical trial, per NIH rules, ONLY clinical trials through the end of Phase IIA are eligible. Progress towards those aims will be updated in required semi-annual reports. It is anticipated that the clinical or translational research project that the trainee is working on under the guidance of their lead mentor will provide the data to be analyzed for their mentored thesis, which is required for those enrolled in the MSCR degree program. Clinical and/or translational research will begin during the first year of the KL2 program. Much of the KL2 scholar’s time in the first year will be devoted to didactic research trainings (e.g., first year of MSCR curriculum). In the second year of the KL2 program, a large portion of the KL2 scholar’s time will be devoted to working on their clinical and/or translational research project, under the guidance of their mentor and completing the MSCR written thesis for those enrolled in the MSCR degree program. The KL2 scholar’s thesis research must be presented to the Georgia CTSA Research Education Executive Committee and the mentoring team at a session scheduled before the final written thesis is submitted to the Graduate School. The KL2 program will provide additional support as well through ongoing functions such as journal club, colloquiums, and special seminars (often in collaboration with the MSCR program or other Georgia CTSA components). Other KL2 scholar’s career development research training activities include leadership training, Science of Team Science training, and mentorship training. The importance of interdisciplinary research will be emphasized in these additional colloquiums and seminars. Each KL2 scholar accepted into the Georgia CTSA KL2 program must submit a mandatory NIH K23 Mentored Patient-Oriented Research Career Development Award or equivalent NIH K award (e.g. K01, K08) grant application by the end of their first 12 months of KL2 funding.

Junior faculty with a doctorate (MD, PhD, MD/PhD, PharmD, or equivalent) at the rank of Instructor or Assistant Professor at Emory, Morehouse School of Medicine (MSM), Georgia Institute of Technology (Georgia Tech), or University of Georgia (UGA) are eligible to apply to the program. Individuals who have accepted a faculty appointment at any of the four collaborating institutions may also apply if they will be on the Emory, MSM, Georgia Tech, or UGA faculty at the date of receipt of the award (e.g., June 1 or July 1). Faculty appointments cannot be dependent upon receipt of this KL2 award. Junior faculty physician candidates should have completed training in a specialty or subspecialty and be board eligible or certified. Non-physician candidates must have a PhD and/or PharmD degrees.

Candidates must be committed to a career in clinical investigation (clinical and/or translational research) and be willing to commit in writing to serve on the faculty of an academic institution pursuing clinical and/or translational research for each year of support received through the KL2 program.

Per NIH guidelines, candidates must be a U.S. citizen or permanent U.S. resident at the time they submit the application. Individuals on temporary or student visas are not eligible.

Also per NIH rules, KL2 scholar applicants may not simultaneously submit or have pending an application for any other PHS mentored career development award (e.g. K01, K07, K08, K22, K23, K25) that duplicates any of the provisions of the KL2 program. Former or current Principal Investigators on any NIH research project grant (e.g. R01, U01) or equivalent non-PHS peer reviewed research grants that are over $100,000 direct costs per year, or project leaders on sub-projects of program project (P01) or center grants (P50) are NOT eligible to participate as KL2 scholars. KL2 scholars are allowed to hold NIH Small Grants (R03) or NIH Exploratory/Developmental (R21) grants or their equivalents and still be eligible for the KL2 award. Appointed KL2 scholars may apply for NIH K23 or equivalent K grant support; if successful, they transfer to the NIH K award.

Requirements 

The candidate must:

  • Be a full time junior faculty member at Emory University, Morehouse School of Medicine, Georgia Institute of Technology, or University of Georgia (Instructor or Assistant Professor or equivalent level) at the time of receipt of the award
  • Indicate a strong interest in pursuing a career in clinical and/or translational research
  • Be nominated by the candidate's Department Chair (and Division Director if applicable); the Chair must guarantee in writing in the letter of support that a minimum of 75% of the junior faculty's professional time will be protected to pursue clinical and/or translational research training if the candidate is accepted into the KL2 program (an exception is made for a minimum of 50% effort for trainees from surgery or surgical subspecialties)
  • Identify an established Emory, MSM, Georgia Tech, or UGA faculty lead mentor who meets approval criteria. Additional faculty members may serve as co-mentors or Advisory Committee members but there must be a designated single lead mentor.

KL2 Application Instructions

All application components should be uploaded to online submission system. Please use online submission system (click to start) to upload your KL2 application files. Once you have started submission by entering your name and email address, you will receive a confirmation email with the link to your KL2 application. You can use this link to upload and update your submission files. Please share your submission link with your Department Chair, Lead mentor, Co-lead mentor (if applicable), and Advisory committee members (if applicable) to upload Letters of Support.

a. Cover Page - Click on the link to view the cover page required.

Formatting your proposal: All sections single spaced, at least one-half inch margins (top, bottom, left, and right). Font size should be 11 points or larger; either Arial, Helvetica, or Georgia typeface.

b. Cover Letter from Applicant should indicate the applicant’s rank (e.g. Instructor, Assistant Professor, etc.) as well as the name of the applicant’s lead mentor. The candidate should indicate their interest in pursuing a career in clinical and/or translational investigation and agree to serve at least one year on the faculty of an academic institution pursuing clinical and/or translational research for each year of support from the KL2 program. The applicant should also state that they will:

  • agree to the rules of the KL2 program
  • meet with the KL2 program director(s) at least once every six months to review progress
  • submit semi-annual progress reports
  • keep the program office updated on publications and grant submissions/awards during AND AFTER completion of the program
  • complete the MSCR or CPTR program unless you have already graduated
  • submit a NIH K23 or other appropriate NIH application (e.g. K01, K08) before the end of their first year in the KL2 program

c. Abstract - 30 lines maximum. Provide an abstract of the entire application (candidate, environment, and research). Include the candidate's immediate and long-term career goals, key elements of the research career development plan, and a description of the research project. In the SF 424 (R&R) Application Guide, there are specific instructions for a K Abstract. Another good place to review funded NIH Individual K abstracts is to study others’ abstracts on the NIH RePORTER (under Activity Code, select K awards).

d. Research and Training Plan: 13 pages total

Specific Aims – 1 page
Candidate Section + Research Strategy – 12 pages

Include a Specific Aims page outlining a brief background for the grant, the hypothesis, and a listing of the specific aims.

As described in the Application Guide, prepare a Candidate Section (Candidate Background; Career Goals and Objectives; Career Development Training Activities) as well as a Research Strategy section (Significance, Innovation and Approach) with a specific focus on the respective K program. The Approachsection will include methods – including human subjects recruitment, statistical analysis plan, anticipated outcomes, potential pitfalls and alternative approaches, and timeline subsections. Preliminary data if any, is not required, but should be included in the appropriate section of the Research Plan.  Preliminary data supporting any aspects of feasibility of the methods is considered to be an advantage. Preliminary data can include published or unpublished findings. Be precise about your role in generating the preliminary data, if any.

The Candidate Section should indicate the candidate’s background and career goals and should also describe the faculty member who will serve as the lead mentor as well as a planned schedule of interactions between the trainee lead mentor and mentoring team (be specific and indicate frequency of meetings, types of interactions, etc.).  For the Career Goals, it is important to describe a compelling plan describing  “Future Plans for NIH Research” which would include at a minimum, a K23, K01, or K08. Applicants who clearly preview the KL2/K12 as a pathway to the NIH K (or similar) tend to receive better scores from reviewers. The Career Development Training Activities should provide a clear description of the didactic training that is planned and may include electives in the second year. Applicants who have already completed a Master’s degree should explain the rationale for the proposed didactic training plan.  The research strategy section will include a hypothesis driven clinical and/or translational research proposal that they would develop under the guidance of their lead mentor as well as plans for didactic and mentored clinical and/or translational research training.  Pilot studies are acceptable.

A Human Subjects/Data Safety and Monitoring Plan (not counted towards the 12 page limit) should be included, if applicable. Please follow the NIH SF 424 Application Guide section for the Protection of Human Subjects.  IRB approval for the research is not required at the time of application but will be required prior to funding.   Another good resource for preparing this section (for all areas of human subjects research) can be found here.

e. Literature Citations: Please include a typical literature citation section at the end of the Research Strategy (not included in the page limit).

f. Budget may be submitted on the NIH SF 424 forms or can be a line item listing and should include applicant’s salary (show total salary as well as 75% requested) along with the current fringe benefit rate which can be found on the Emory Office of Sponsored Programs website. Also include a technical budget of $25,000 per year (which should include $10,000 in year one for MSCR tuition for applicants who propose to complete the MSCR program, and $2,500 per year maximum for travel. KL2 scholars should plan to attend annual Southeast Regional Clinical and Translational Science Conference and Translational Science meeting in Washington, DC.) and a budget justification of no more than two pages. Do not include items not allowed on Federal Grants such as software, books, and administrative support staff (ask if uncertain).

g. Letters of Support from the lead mentor and Department Chair - The letter from the Department Chair must guarantee that the applicant will have protected time (equivalent to the salary support provided by the program) to carry out clinical research training if accepted into the KL2 program. If the candidate is in the Department of Medicine, a letter from the Division Director is required in lieu of or in addition to the Department Chair. The lead mentor’s letter should reflect willingness to serve as mentor for the candidate, the mentor's assessment of the candidate, prior trainees he/she has mentored, a brief summary of the applicant’s research proposal, and a brief summary of plans for mentoring and enhancing the research capabilities of the applicant. If there are co-mentors, consultants and/or collaborators, the commitment and role of these individuals should be clearly stated.  The mentor should include detailed information on what portion of the applicant’s time will be devoted to clinical activities and what will be the clinical activities and responsibilities once accepted into the K program. The K program requires a minimum of 75% protected effort (50% minimum for surgery department faculty). Letters of support for the candidate from applicant’s proposed advisory committee members are also required. Note: these are not letters of recommendation but rather letters of support to mentor the candidate.

h. NIH Biosketch and Other Support Page of candidate and lead mentor as well as co-lead mentor (if applicable), advisors and collaborators (if any). The NIH biosketch instructions for the K awards and an example of the NIH biosketch can be found on this website. Other support pages are not required for advisors and collaborators.

i. Facilities and Other Resources, Equipment: 2 pages.

j. Application fee in the amount of $75.00 payable to Emory University (if your application is successful). If you are currently enrolled at Emory University, no application fee is charged by the University. Deliver to the program office (see below). 

k. Original transcripts from every secondary institution you have attended except Emory. Once you are accepted into the program, your transcripts can be sent by the issuing institution directly to the Laney Graduate School or you can deliver original, official transcripts in envelopes sealed by the issuing institutions to:

Cheryl Sroka
Rm 6.112, 1599 Building
1599 Clifton Road NE
Emory University
Atlanta, Georgia 30322

(For resubmissions only: Please add a one-page Introduction that outlines the weaknesses and concerns of the previous reviews and how you have addressed those in this submission. This page will not count toward the 13-page limit.)

Selection/Review Criteria

The selection process will be carried out under the direction of the Georgia CTSA Research Education Executive Committee, which has established the rules and regulations for the KL2 program. The goal of the KL2 program is to select candidates who, with proper career development and clinical and/or translational research training, have potential to become independently funded, successful, and ethical clinical investigators. Decisions will be based on the strength of the application submitted by the prospective trainee, the potential of the applicant, the success and track record of the lead mentor in mentoring previous junior faculty members and other trainees and diversity issues. Decisions of the KL2 Review Panel are final. Applications will be scored using the NIH scoring system (1 to 9 point scale).

Plan for Recruitment and Retention of Underrepresented Minorities, Women, and those with Disabilities

The KL2 program is committed to meeting the NIH/NCATS goal and that of Emory University, MSM, Georgia Tech, and UGA to increase the participation of women and individuals from ethnic or racial groups underrepresented in the biomedical and behavioral sciences. Such groups include American Indian or Alaska native, Asian, Black or African American, Hispanic or Latino, and Native Hawaiian or Other Pacific Islander. Applications from women and minority candidates are encouraged. In addition, accommodations will be made to assist any individuals with disabilities so those persons who are qualified applicants can complete the program.

Questions: We encourage interested KL2 candidates to contact the Georgia CTSA education program leadership for questions and assistance with the application process. Questions on the application process can be directed to Cheryl Sroka, Georgia CTSA Research Education Program Coordinator (csroka@emory.edu or 404.727.5096).  For questions, especially technical issues, or problems with the online submission website please contact Alexey Kurbatov (akurbat@emory.edu). Applicants are also encouraged to contact the KL2 Co-Directors for additional information.

Each junior faculty trainee must identify a lead mentor who is an established, independently funded clinical and/or translational investigator at one of the collaborating institutions (Emory, MSM, Georgia Tech, or UGA). Lead mentors should be established and successful clinical and/or translational investigators with a strong mentoring track record. Generally this means that the lead investigator must be a federally-funded investigator (e.g., NIH and/or CDC). A faculty mentor may only serve as lead mentor for a single KL2 applicant or scholar at any one time.

A letter of support from the lead mentor indicating their willingness and desire to serve as the trainee's lead mentor should be included in the candidate's application. All KL2 scholars must have mentored clinical and/or translational research training under the direction of their lead mentor. Additional co-mentors or Advisory Committee members are permitted; however, there must be a single lead mentor that is identified. Multidisciplinary mentoring teams are strongly encouraged as is having representation from at least two of the Georgia CTSA partners on the mentoring team or Advisory Committee (Emory, MSM, Georgia Tech, or UGA).

Junior faculty members accepted into the KL2 program must devote a minimum of 75% professional effort to clinical and/or translational research training (the only exception to this is a minimum of 50% effort for trainees from surgery or surgical subspecialties). Salary support reflecting effort will be provided by the KL2 program (as well as the costs to cover fringe benefits on that salary). Salary support is based on the trainee's current institutional salary. The maximum salary support that the KL2 program can provide is $120,000 per year (plus fringe benefits). Ongoing support for year two is contingent upon the trainee making adequate progress in the program. In addition to salary support, up to $25,000 per year will be provided to each trainee for a technical budget. These funds must be used to pay for MSCR tuition (if applicable) while the trainee is in the KL2 program and can also be used for other research related needs including research supplies, equipment, non-faculty research staff salary support, and travel to national meetings or to receive additional specialized training. Salary support for the lead mentor is not allowed by NIH.

Source of Support

Funding for the KL2-MCTRS comes from the Georgia CTSA through a National Institutes of Health (NIH) funded Clinical and Translational Science Award (CTSA) received by Emory University (in collaboration with MSM, Georgia Tech, and UGA).

Lauren F. Collins, MD, MSc

Emory University

Assistant Professor of Medicine, Division of Infectious Disease, School of Medicine

lauren.frances.collins@emory.edu

Lead Mentor: Igho Ofotokun, MD, MSc

Lauren F. Collins, MD, MSc is an Assistant Professor of Medicine in the Division of Infectious Diseases at Emory University. She is a recent KL2 career development awardee supported by the Georgia Clinical and Translational Science Alliance with Dr. Igho Ofotokun as her primary mentor. Her project evaluates the use of a novel retinovascular imaging tool to explore microvascular dysfunction as a common pathogenesis – and potential screening target – of age-related comorbidities among women with and without HIV. Dr. Collins’ clinical and research interests focus on improving the care of persons with HIV and in particular, women with HIV and those affected by the Southern HIV/AIDS epidemic. In her research, she studies the mounting burden of non-AIDS comorbidities experienced by aging persons with HIV and specifically investigates the role of sex differences, shared mechanistic drivers, and traditional and HIV-specific risk factors contributing to overall comorbidity burden. She is also interested in the clinical, service delivery and public health implications of coinfections affecting persons with HIV, namely chronic HCV and SARS-CoV-2. Dr. Collins is a co-investigator for the Women’s Interagency HIV Study (WIHS) and the Emory Specialized Center of Research Excellence on Sex Differences (SCORE).

Complete list of Dr. Collins’ published work



Carmen M. Dickinson-Copeland, PhD, MSCR

Morehouse School of Medicine

Instructor, Department of Microbiology, Biochemistry and Immunology

cdcopeland@msm.edu

Lead Mentor: Priscilla E. Igho-Pemu, MBBS, MSCR, FACP

Dr. Dickinson-Copeland is an Instructor in the Department of Microbiology, Biochemistry and Immunology at Morehouse School of Medicine. Her KL2 research is entitled "Progenitor cell response to lead exposure in children from rural versus urban counties in Georgia,” which focuses on the identification of molecular biomarkers, socioeconomic and environmental risk factors associated with lead exposure and toxicity among children living in both rural and urban settings. Dr. Dickinson-Copeland's research combines her biomedical translational experience with her training in health policy leadership. Her doctoral thesis included the identification and assessment of the functional roles of biomarkers for microvascular dysfunction in pediatric cerebral malaria. As a fellow of the Satcher Health Policy Leadership Institute, she received training in leadership development, health policy, and health equity. Dr. Dickinson-Copeland’s long-term goal is to advance health equity through the collaborative development of evidence-based health policy.

Complete list of Dr. Dickinson-Copeland’s published work



Ronald C. Eldridge, PhD, MPH

Emory University

Research Assistant Professor, Nell Hodgson Woodruff School of Nursing

ronald.eldridge@emory.edu

Lead Mentor: Deborah Watkins Bruner, RN, PhD, FAAN

Dr. Eldridge is a Research Assistant Professor at the Nell Hodgson Woodruff School of Nursing. His background and expertise in epidemiology, public health, and methods has driven his research in the biological mechanisms related to cancer prevention and clinical translation. In his KL2 project titled “Progressing towards precision medicine in human papillomavirus and non-human papillomavirus head and neck cancer through high-resolution metabolomics”, Dr. Eldridge is using the cutting edge in omics research to metabolically characterize HPV-associated and non-HPV-associated head and neck cancer patients. He will then pair that metabolomics data with machine learning algorithms to predict head and neck cancer patient survival.

Complete list of Dr. Eldridge’s published works



Ida Tchuisseu Fonkoue, MD, PhD

Emory University

Instructor of Medicine, Renal Division, Department of Medicine, School of Medicine

ida.tchuisseu.fonkoue@emory.edu

Lead Mentor: Jeanie Park, MD, MS

Co-Mentor: Vasiliki Michopoulos, PhD, MSCR

Dr. Fonkoue is an Instructor of Medicine in the Renal Division at Emory University School of Medicine. Her KL2 research entitled " Vascular and Neural Consequences of Post-traumatic Stress (PTSD) in Premenopausal Women,” aims to determine if PTSD in premenopausal women causes endothelial, neural and hormonal changes linked to an increased risk of hypertension and cardiovascular disease (CVD). She has previously published data highlighting the autonomic dysregulation present in PTSD patients. Dr. Fonkoue's academic training and research experience have provided her with an excellent background in both clinical medicine, and basic integrative physiology. While she practiced as a physician in Cameroon, she currently works as a translational researcher. Dr. Fonkoue’s mission as a scientist is to investigate how the autonomic nervous system, the vasculature and the kidneys interact to contribute to the high cardiovascular risk of patients living with chronic stress exposure. Specifically, she is establishing a scientific niche focused on distinct neurocirculatory and hormonal mechanisms linking stress and CVD risk in women.

Complete list of Dr. Fonkoue’s published work



Laren Narapareddy, PhD, RN

Emory University

Tenure-Track Assistant Professor, Nell Hodgson Woodruff School of Nursing

laren.narapareddy@emory.edu

Lead Mentor: Carmen Marsit, PhD

Lead Mentor: Alicia Smith

Dr. Narapareddy is an Assistant Professor at the Nell Hodgson Woodruff School of Nursing. She completed her PhD in Nursing Science at University of Illinois Chicago and her postdoctoral training at the University of Pennsylvania in Penn’s Epigenetics Institute. Dr. Narapareddy’s research is interdisciplinary and focuses on optimizing fertility and reproductive outcomes. In her KL2 project titled “Placental Epigenetic Profiles and Maternal Depression/Anxiety in Pregnancies Conceived Through Assisted Reproductive Technologies”, Dr. Narapareddy uses epigenome-wide methodologies to understand how fertility treatments and maternal depression/anxiety regulate placental function through epigenetic mechanisms. The long-term goal of this work is to identify potentially modifiable clinical factors that can inform prevention and intervention strategies to optimize health outcomes for women and children following fertility treatments.

Complete list of Dr. Narapareddy’s published work



Andrea Sikora Newsome, PharmD, BCPS, BCCCP

University of Georgia

Clinical Assistant Professor, The University of Georgia College of Pharmacy
Critical Care Clinical Pharmacist, Augusta University Medical Center

sikora@uga.edu

Lead Mentor: Somanath P.R. Shenoy, MSc, PhD, FAHA

Dr. Andrea Sikora Newsome is a Clinical Assistant Professor at The University of Georgia College of Pharmacy. She completed her Doctor of Pharmacy training at The University of Georgia College of Pharmacy followed by two years of post-graduate residency training at The University of North Carolina Medical Center specializing in critical care. Her practice site is Augusta University Medical Center in Augusta, GA. Her area of research interest is the vascular and hemodynamic changes that occur in critical illness. Her KL2 project is entitled "Stromelysin-1 (MMP3) as a diagnostic and prognostic biomarker for acute respiratory distress syndrome."

Complete list of Dr. Newsome’s published work



Lisa R. Staimez, PhD, MPH

Emory University

Assistant Professor, Rollins School of Public Health, Hubert Department of Global Health

lrlevy@emory.edu

Lead Mentor: Karen Conneely, PhD

Dr. Staimez leads epidemiologic and translational research to reduce health disparities in diabetes and other chronic diseases globally. Her long-term objective is to identify new strategies to prevent diabetes, particularly before the grim complications of the disease set in. Dr. Staimez’s research integrates epidemiology, laboratory sciences, pathophysiology, epigenetics, and nutrition. As a faculty member of the Emory Global Diabetes Research Center, Dr. Staimez’s work includes clinical and population cardiometabolic studies in the U.S. and in India. She is also a faculty member in the Emory Nutrition and Health Sciences program and teaches about metabolic processes related to diabetes and other chronic diseases. Prior to coming to Emory, Dr. Staimez managed and evaluated programs at the Centers for Disease Control and Prevention, including the WISEWOMAN program (Well-Integrated Screening and Evaluation for WOMen Across the Nation). She also assessed community health and the nutritional status of young children in Guatemala and El Salvador. Areas of research include: heterogeneity in diabetes processes across populations, diabetes and cardiometabolic risk across the life course, diabetes in youth, and impacts of lifestyle interventions, particularly nutrition- and diet- based interventions on reducing chronic diseases.

Complete list of Dr. Staimez’s published work



Aaron Trammell, MD, MSc

Emory University

Assistant Professor of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, School of Medicine

awtramm@emory.edu

Lead Mentor: C. Michael Hart, MD

Dr. Trammell is Assistant Professor of Medicine at Emory University School of Medicine. He has clinical and research focus in pulmonary hypertension, a state of abnormally elevated blood pressure in the lungs. Dr. Trammell’s KL2 project, “Metabolic dysfunction and pulmonary hypertension”, will explore the impact of metabolic disease in complementary epidemiologic and translational studies. Prior work from others supports a role of insulin resistance in pulmonary arterial hypertension, a rare subset of pulmonary hypertension. In his KL2 work, he will use a longitudinal cohort he developed from VA data to estimate the impact of diabetes and its treatments on outcome in veterans with more common forms of pulmonary hypertension. Additionally, he will work with laboratory collaborators to describe differences in mitochondrial metabolism between subjects with and without pulmonary hypertension.

Complete list of Dr. Trammell’s published works



Contact